AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 283: G794-G800, 2002. First published April 10, 2002; doi:10.1152/ajpgi.00363.2001
0193-1857/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/3/G794    most recent
00363.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Acker, G. J. D.
Right arrow Articles by Steer, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Acker, G. J. D.
Right arrow Articles by Steer, M. L.
Vol. 283, Issue 3, G794-G800, September 2002

Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity

Gijs J. D. van Acker, Ashok K. Saluja, Lakshmi Bhagat, Vijay P. Singh, Albert M. Song, and Michael L. Steer

Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Intrapancreatic activation of trypsinogen is believed to play a critical role in the initiation of acute pancreatitis, but mechanisms responsible for intrapancreatic trypsinogen activation during pancreatitis have not been clearly defined. In previous in vitro studies, we have shown that intra-acinar cell activation of trypsinogen and acinar cell injury in response to supramaximal secretagogue stimulation could be prevented by the cell permeant cathepsin B inhibitor E64d (Saluja A, Donovan EA, Yamanaka K, Yamaguchi Y, Hofbauer B, and Steer ML. Gastroenterology 113: 304-310, 1997). The present studies evaluated the role of intrapancreatic trypsinogen activation, this time under in vivo conditions, in two models of pancreatitis by using another highly soluble cell permeant cathepsin B inhibitor, L-3-trans-(propylcarbamoyl)oxirane-2-carbonyl-L-isoleucyl-L-proline methyl ester (CA-074me). Intravenous administration of CA-074me (10 mg/kg) before induction of either secretagogue-elicited pancreatitis in mice or duct infusion-elicited pancreatitis in rats markedly reduced the extent of intrapancreatic trypsinogen activation and substantially reduced the severity of both pancreatitis models. These observations support the hypothesis that, during the early stages of pancreatitis, trypsinogen activation in the pancreas is mediated by the lysosomal enzyme cathepsin B. Our findings also suggest that pharmacological interventions that inhibit cathepsin B may prove useful in preventing acute pancreatitis or reducing its severity.

zymogens


This article has been cited by other articles:


Home page
 GutHome page
V Dudeja, S M Vickers, and A K Saluja
The role of heat shock proteins in gastrointestinal diseases
Gut, July 1, 2009; 58(7): 1000 - 1009.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
J. M Laukkarinen, G. J D Van Acker, E. R Weiss, M. L Steer, and G. Perides
A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate
Gut, November 1, 2007; 56(11): 1590 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
V. P Singh, L. Bhagat, S. Navina, R. Sharif, R. K Dawra, and A. K Saluja
Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion
Gut, July 1, 2007; 56(7): 958 - 964.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. J. D. Van Acker, E. Weiss, M. L. Steer, and G. Perides
Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1738 - G1746.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. W. Sherwood, I. A. Prior, S. G. Voronina, S. L. Barrow, J. D. Woodsmith, O. V. Gerasimenko, O. H. Petersen, and A. V. Tepikin
Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells
PNAS, March 27, 2007; 104(13): 5674 - 5679.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Sharma, X. Tao, A. Gopal, B. Ligon, P. Andrade-Gordon, M. L. Steer, and G. Perides
Protection against acute pancreatitis by activation of protease-activated receptor-2
Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G388 - G395.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online